Sigyn Therapeutics Inc. (SIGY)

Overview

Sigyn Therapeutics, Inc. is identified as a development-stage enterprise, singularly focused on advancing the realm of therapeutic technology. Predominantly, it devotes its research and developmental efforts towards the inception of Sigyn Therapy. This innovative blood purification technology emerges as a beacon of hope, aiming to transcend the constraints historically faced by drugs and devices in the management of perilous inflammatory conditions. Among such conditions, sepsis stands out, notorious as a leading cause of mortality within hospital settings. With its headquarters firmly established in San Diego, California, Sigyn Therapeutics positions itself at the forefront of innovation within the biotechnological landscape.

Products and Services

• Sigyn Therapy - This flagship innovation by Sigyn Therapeutics is meticulously designed for the blood purification process, with a laser focus on addressing and managing life-threatening inflammatory disorders. Central to its purpose is the treatment of sepsis, a significant factor behind hospital-related deaths, showcasing the therapy's critical role in healthcare.

In addition to its primary focus, Sigyn Therapy explores its potential efficacy against a wide array of therapeutic targets. This includes but is not limited to:

• Endotoxin: A potent trigger for inflammation and sepsis, representing a critical target in the therapy's scope.
• Peptidoglycan and Lipoteichoic Acid: Key components of bacterial cell walls that play a substantial role in the inflammation process, especially in gram-positive bacteria.
• Viral Pathogens: The therapy aims to mitigate the effect of viral infections that can exacerbate or lead to inflammatory conditions.
• Hepatic Toxins: Targets toxins affecting liver function, which can be a byproduct or cause of systemic inflammation.
• CytoVesicles: Focuses on cellular components associated with the transportation and communication of inflammatory signals.
• Tumor Necrosis Factor Alpha, Interleukin-1 Beta, and Interleukin 6: These pro-inflammatory cytokines are pivotal in the body's immune response; however, their overproduction can lead to harmful inflammation. Sigyn Therapy endeavors to moderate their levels, thereby controlling the inflammatory response.